Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
The Australasian Journal of Dermatology|August 14, 2014
Non-infectious skin disease in Indigenous AustraliansChristopher Heyes, Clare Tait, Ryan Toholka, et al.The Australasian Journal of Dermatology|April 29, 2015
Serum 25-hydroxyvitamin D increases with NB-UVB and UVA/UVB phototherapy in patients with psoriasis and atopic dermatitis in Western AustraliaPatricia Le, Jenny Tu, Kurt Gebauer, et al.The Australasian Journal of Dermatology|July 12, 2017
Dental patch testing in patients with undifferentiated oral lichen planusShevya M Tiwari, Kurt Gebauer, Agnieszka M Frydrych, et al.Journal of Drugs in Dermatology : JDD|October 14, 2015
Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept StudyDedee F Murrell, Kurt Gebauer, Lynda Spelman, et al.The Australasian Journal of Dermatology|January 31, 2009
PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa studyGreg Siller, Kurt Gebauer, Peter Welburn, et al.Cutis|July 30, 2010
Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year studyChristopher Quirk, Kurt Gebauer, Brian De'Ambrosis, et al.The Australasian Journal of Dermatology|August 13, 2011
Dermatology outpatient population profiling: indigenous and non-indigenous dermatoepidemiologyChristopher Heyes, Jonathan Chan, Anne Halbert, et al.Frontiers in Pharmacology|April 1, 2017
East Indian Sandalwood Oil (EISO) Alleviates Inflammatory and Proliferative Pathologies of PsoriasisManju Sharma, Corey Levenson, Ian Clements, et al.The Australasian Journal of Dermatology|February 5, 2013
Primary localized cutaneous nodular amyloidosis successfully treated with cyclophosphamidePhilip L Tong, William A Walker, Ross J Glancy, et al.International Journal of Dermatology|November 26, 2009
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access programPeter Foley, Michael Freeman, Kurt Gebauer, et al.Pageof 4